HCPCS Code J9145: Injection, Daratumumab, 10 mg

Darzalex (daratumumab) is an immunotherapy, specifically a monoclonal antibody, not traditional chemotherapy. It targets the CD38 protein on multiple myeloma cells, helping the immune system recognize and destroy these cancer cells.

Daratumumab injection treats multiple myeloma by binding to CD38 on cancerous plasma cells, leading to their destruction. It is used alone or with other drugs to control the progression of this bone marrow cancer.

The HCPCS code for platelet-rich plasma (PRP) injection is often C9276, which covers autologous PRP obtained by centrifugation and injected for therapeutic purposes. Other related codes may be used depending on the procedure and payer policies.